Half year 2024
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Major Shareholder Announcement
- Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer
- AB Tewox publishes its factsheet for Q3 2026
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share